I've learned to steer clear of biotech SP over 10c until the biotech is at least in P2 trials.
Unless its a wonder drug that attracts partners early on, you can be sure the SP will dip below 10c or even below 1c along the way.
Even the 2.4c buyers today may rue their purchase if SP dips below 1c (always a possibility with biotech).
- Forums
- ASX - By Stock
- CHM
- Ann: 1st patient dosed in CHM 0201 Vactosertib trial
Ann: 1st patient dosed in CHM 0201 Vactosertib trial, page-15
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
CHM (ASX) Chart |
Day chart unavailable